There are currently 6 subscribing organizations funding GAiT activity:
The Cell and Gene Therapy Catapult (CGT)
The Centre for Commercialization of Regenerative Medicine (CCRM)
The Korean HLA-matched iPSC Banking Initiative (KHiB)
The New York Stem Cell Foundation (NYSCF)
French National Institute of Health and Medical research (INSERM)
Each subscribing organization has a Director on the GAiT Board:
CGTC: Dr Jacqueline Barry
CCRM: Dr Michael May
KHiB: Prof Jihwan Song
NYSCF: Ms Susan Solomon
INSERM: Prof Annelise Bennaceur Griscelli
HKU: Prof Ronald Li
